Stryker Corporation Buyback
OLI recorded this information on 3/3/2015
Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has authorized a new $2 billion share repurchase program. The program is in addition to $583 million of existing authorization remaining under the Company's current share repurchase programs, bringing the Company's total share repurchase authorization to $2.583 billion.
Stryker is a medical technology company. Co. provides products and services in orthopaedics, medical and surgical, and neurotechnology and spine. Co.'s Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. Co.'s MedSurg products include surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices and other medical device products used in a range of medical specialties. Co.'s Neurotechnology and Spine products include neurosurgical, neurovascular, and spinal implant devices.
Stryker SEC Filing Email Alerts Service
Open the SYK Page at The Online Investor »
Buy (3.15 out of 4)